134 related articles for article (PubMed ID: 37800826)
1. Flash'O real-world evidence programme - Attitude and practices toward the use of omega-3 FA by physicians from Middle East Countries.
Kinsara AJ; Sabbour H
Medicine (Baltimore); 2023 Oct; 102(40):e35416. PubMed ID: 37800826
[TBL] [Abstract][Full Text] [Related]
2. Physicians' perceptions and beliefs on the current dyslipidemia management practices within Saudi Arabia.
Almigbal TH; Almunif DS; Ali Deshisha E; Altaradi H; Alrasheed AA; Batais MA; Alhabib KF
Saudi Pharm J; 2023 Oct; 31(10):101759. PubMed ID: 37705879
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of heart disease--knowledge among cardiologists and omega-3 (omega-3) fatty acid prescribing behaviors in Karachi, Pakistan.
Gowani SA; Shoukat S; Taqui AM; Hanif HM; Rawasia WF; Qadri Z; Dhakam SH
BMC Cardiovasc Disord; 2009 Jan; 9():4. PubMed ID: 19173721
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.
Barter P; Ginsberg HN
Am J Cardiol; 2008 Oct; 102(8):1040-5. PubMed ID: 18929706
[TBL] [Abstract][Full Text] [Related]
5. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
6. Fish oil in the treatment of dyslipidemia.
Goldberg RB; Sabharwal AK
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):167-74. PubMed ID: 18316953
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of internal medicine physicians' attitudes toward the treatment of dyslipidemia.
Kara E; Tecen Yucel K; Bayraktar-Ekincioglu A; Demirkan K; Tokgozoglu L; Unal S
Postgrad Med; 2020 Aug; 132(6):538-543. PubMed ID: 32345082
[No Abstract] [Full Text] [Related]
8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
9. Cultural Barriers in the Treatment of Dyslipidemia: A Survey of Japanese Physician Attitudes.
Yamashita S; Masuda D; Arai H; Matsuzawa Y
J Atheroscler Thromb; 2019 Feb; 26(2):154-169. PubMed ID: 29780067
[TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy and safety of combination therapy with statins and omega-3 fatty acids versus statin monotherapy in patients with dyslipidemia: A systematic review and meta-analysis.
Choi HD; Chae SM
Medicine (Baltimore); 2018 Dec; 97(50):e13593. PubMed ID: 30558030
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia.
Pirillo A; Catapano AL
Atheroscler Suppl; 2013 Aug; 14(2):237-42. PubMed ID: 23958479
[TBL] [Abstract][Full Text] [Related]
12. Adherence to Current Lipid Guidelines by Physicians in Kuwait.
Alhajji S; Mojiminiyi S
Med Princ Pract; 2020; 29(5):436-443. PubMed ID: 31805555
[TBL] [Abstract][Full Text] [Related]
13. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
Weintraub H
Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
[TBL] [Abstract][Full Text] [Related]
14. Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.
Benes LB; Bassi NS; Kalot MA; Davidson MH
Cardiol Clin; 2018 May; 36(2):277-285. PubMed ID: 29609757
[TBL] [Abstract][Full Text] [Related]
15. Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment.
Al Sifri SN; Almahmeed W; Azar S; Okkeh O; Bramlage P; Jünger C; Halawa I; Ambegaonkar B; Wajih S; Brudi P
PLoS One; 2014; 9(1):e84350. PubMed ID: 24400085
[TBL] [Abstract][Full Text] [Related]
16. The role of selective imidazoline receptor agonists in modern hypertension management: an international real-world survey (STRAIGHT).
Schlaich MP; Almahmeed W; Arnaout S; Prabhakaran D; Zhernakova J; Zvartau N; Schutte AE
Curr Med Res Opin; 2020 Dec; 36(12):1939-1945. PubMed ID: 33047993
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: a case-control study in Korea.
Kim YJ; Jeong DW; Lee JG; Lee HC; Lee SY; Kim YJ; Yi YH; Park YS; Cho YH; Bae MJ; Choi EJ
Lipids Health Dis; 2012 Mar; 11():43. PubMed ID: 22448615
[TBL] [Abstract][Full Text] [Related]
18. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
[TBL] [Abstract][Full Text] [Related]
19. Real-world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain, and the United Kingdom.
Tai MH; Shepherd J; Bailey H; Williams N; Hatz M; Campos Tapias I; Catterick D; Worth G
Curr Med Res Opin; 2019 May; 35(5):829-835. PubMed ID: 30289004
[TBL] [Abstract][Full Text] [Related]
20. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
